Literature DB >> 10622535

Differential expression of facilitative glucose transporter (GLUT) genes in primary lung cancers and their liver metastases.

T Kurata1, T Oguri, T Isobe, S Ishioka, M Yamakido.   

Abstract

Glucose uptake is mediated by members of the facilitative glucose transporter (GLUT) family. Malignant cells take up more glucose than their normal counterparts. The aim of this study was to investigate the gene expression levels of the GLUT family, especially GLUT1, GLUT3, and GLUT5 in primary lung cancer, metastatic liver tumors, and normal lung tissues, and to compare the expression levels of primary and metastatic tumors with those of normal tissues. We analyzed 105 autopsy samples (35 primary lung tumors, 35 corresponding normal lung tissues, 25 normal liver tissues, and 10 metastatic liver tumors) from 35 patients using the quantitative reverse transcription polymerase chain reaction. The GLUT1 gene expression levels in primary lung tumors were significantly higher than those in normal lung tissues. In liver metastatic lesions, the GLUT3 and GLUT5 gene expression levels were significantly higher than those in primary lung tumors, but there were no differences in GLUT1 expression levels between primary and metastatic liver tumors. Our results show that the gene expression pattern of the GLUT family is different between primary and metastatic liver tumors and suggest that the energy transporters in metastatic tumors may be different from those in primary tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10622535      PMCID: PMC5926010          DOI: 10.1111/j.1349-7006.1999.tb00702.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  27 in total

1.  Glucose-transporter-type-I-gene amplification correlates with sialyl-Lewis-X synthesis and proliferation in lung cancer.

Authors:  J Ogawa; H Inoue; S Koide
Journal:  Int J Cancer       Date:  1997-04-22       Impact factor: 7.396

2.  Erythrocyte/HepG2-type glucose transporter is concentrated in cells of blood-tissue barriers.

Authors:  K Takata; T Kasahara; M Kasahara; O Ezaki; H Hirano
Journal:  Biochem Biophys Res Commun       Date:  1990-11-30       Impact factor: 3.575

3.  Over-expression of facilitative glucose transporter genes in human cancer.

Authors:  T Yamamoto; Y Seino; H Fukumoto; G Koh; H Yano; N Inagaki; Y Yamada; K Inoue; T Manabe; H Imura
Journal:  Biochem Biophys Res Commun       Date:  1990-07-16       Impact factor: 3.575

Review 4.  Transport of sugars in tumor cell membranes.

Authors:  M Hatanaka
Journal:  Biochim Biophys Acta       Date:  1974-04-29

5.  A possible role for a mammalian facilitative hexose transporter in the development of resistance to drugs.

Authors:  J C Vera; G R Castillo; O M Rosen
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

6.  Expression of the fructose transporter GLUT5 in human breast cancer.

Authors:  S P Zamora-León; D W Golde; I I Concha; C I Rivas; F Delgado-López; J Baselga; F Nualart; J C Vera
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

7.  Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study.

Authors:  R S Brown; R L Wahl
Journal:  Cancer       Date:  1993-11-15       Impact factor: 6.860

8.  Expression of glucose transporters in head-and-neck tumors.

Authors:  P Mellanen; H Minn; R Grénman; P Härkönen
Journal:  Int J Cancer       Date:  1994-03-01       Impact factor: 7.396

9.  Expression of gamma-glutamylcysteine synthetase (gamma-GCS) and multidrug resistance-associated protein (MRP), but not human canalicular multispecific organic anion transporter (cMOAT), genes correlates with exposure of human lung cancers to platinum drugs.

Authors:  T Oguri; Y Fujiwara; T Isobe; O Katoh; H Watanabe; M Yamakido
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

10.  Apoptosis is regulated by the rate of glucose transport in an interleukin 3 dependent cell line.

Authors:  O Kan; S A Baldwin; A D Whetton
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  28 in total

1.  [18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung.

Authors:  Marcelo Mamede; Tatsuya Higashi; Masanori Kitaichi; Koichi Ishizu; Takayoshi Ishimori; Yuji Nakamoto; Kazuhiro Yanagihara; Mio Li; Fumihiro Tanaka; Hiromi Wada; Toshiaki Manabe; Tsuneo Saga
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

2.  Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.

Authors:  Jeremy V Camp; Ulas Bagci; Yong-Kyu Chu; Brendan Squier; Mostafa Fraig; Silvia M Uriarte; Haixun Guo; Daniel J Mollura; Colleen B Jonsson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

3.  Single-Step Assembly of Multimodal Imaging Nanocarriers: MRI and Long-Wavelength Fluorescence Imaging.

Authors:  Nathalie M Pinkerton; Marian E Gindy; Victoria L Calero-DdelC; Theodore Wolfson; Robert F Pagels; Derek Adler; Dayuan Gao; Shike Li; Ruobing Wang; Margot Zevon; Nan Yao; Carlos Pacheco; Michael J Therien; Carlos Rinaldi; Patrick J Sinko; Robert K Prud'homme
Journal:  Adv Healthc Mater       Date:  2015-04-30       Impact factor: 9.933

Review 4.  Glucose transporters in the uterus: an analysis of tissue distribution and proposed physiological roles.

Authors:  Antonina I Frolova; Kelle H Moley
Journal:  Reproduction       Date:  2011-06-03       Impact factor: 3.906

Review 5.  Hepatic expression and cellular distribution of the glucose transporter family.

Authors:  Sumera Karim; David H Adams; Patricia F Lalor
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

6.  Clinical significance of GLUT-1 expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.

Authors:  Itaru Chiba; Kazuhiko Ogawa; Takamitsu Morioka; Hideaki Shimoji; Nao Sunagawa; Shiro Iraha; Tadashi Nishimaki; Naomi Yoshimi; Sadayuki Murayama
Journal:  Oncol Lett       Date:  2010-10-27       Impact factor: 2.967

7.  GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling.

Authors:  Wen-Lian Chen; Xing Jin; Mingsong Wang; Dan Liu; Qin Luo; Hechuan Tian; Lili Cai; Lifei Meng; Rui Bi; Lei Wang; Xiao Xie; Guanzhen Yu; Lihui Li; Changsheng Dong; Qiliang Cai; Wei Jia; Wenyi Wei; Lijun Jia
Journal:  JCI Insight       Date:  2020-02-13

Review 8.  18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.

Authors:  Hossein Jadvar; Abass Alavi; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

9.  Sugar transport by mammalian members of the SLC26 superfamily of anion-bicarbonate exchangers.

Authors:  J-M Chambard; J F Ashmore
Journal:  J Physiol       Date:  2003-08-01       Impact factor: 5.182

10.  Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma.

Authors:  Chun-Ta Huang; Rouh-Fang Yen; Mei-Fang Cheng; Ya-Chieh Hsu; Pin-Fei Wei; Yi-Ju Tsai; Meng-Feng Tsai; Jin-Yuan Shih; Chih-Hsin Yang; Pan-Chyr Yang
Journal:  Med Oncol       Date:  2009-01-07       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.